Amgen Inc. $AMGN Stock Position Decreased by Ameriprise Financial Inc.

NodeGuardian · 2026-03-17T19:55:19+00:00

Ameriprise Financial cut its Amgen stake by 18.9%, selling 467,013 shares but still holding over 2 million. Amgen reported strong earnings with an 8.6% revenue increase and positive FY 2026 guidance, while institutional investors own 76.50% of the stock.

NodeGuardian

2026-03-17 19:55:19

Abstract generation in progress

Ameriprise Financial Inc. significantly reduced its stake in Amgen Inc. by 18.9% in the third quarter, selling 467,013 shares while still retaining over 2 million shares valued at approximately $563.85 million. This comes as Amgen reported strong quarterly earnings, beating expectations with revenue up 8.6% year-over-year, and issued positive guidance for FY 2026, alongside declaring a quarterly dividend. Despite Ameriprise’s reduced position, institutional investors and hedge funds collectively own a substantial 76.50% of Amgen’s stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes